Inivata Ltd:企業の製品パイプライン分析

◆英語タイトル:Inivata Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2331550PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotide variants, insertions and deletions and structural variants in selected genes from DNA isolated from plasma samples from patients with non-small cell lung cancer; and InVisionSeq test. Inivata works with industry and academic researchers to develop new clinical applications for liquid biopsy and ctDNA analysis. The company operates in the UK and the US. Inivata is headquartered in Cambridge, Cambridgeshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Inivata Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Inivata Ltd Company Overview
Inivata Ltd Company Snapshot
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd – Pipeline Analysis Overview
Inivata Ltd – Key Facts
Inivata Ltd – Major Products and Services
Inivata Ltd Pipeline Products by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Pipeline Products Overview
InVision ctDNA Assay – EGFR-Mutant NSCLC
InVision ctDNA Assay – EGFR-Mutant NSCLC Product Overview
InVision ctDNA Assay – Metastatic Breast Cancer
InVision ctDNA Assay – Metastatic Breast Cancer Product Overview
InVision ctDNA Assay – NSCLC
InVision ctDNA Assay – NSCLC Product Overview
InVision ctDNA Assay – NSCLC Clinical Trial
InVision ctDNA Assay – Pancreatic Cancer
InVision ctDNA Assay – Pancreatic Cancer Product Overview
InVision ctDNA Assay – Stage III/IV NSCLC
InVision ctDNA Assay – Stage III/IV NSCLC Product Overview
Inivata Ltd – Key Competitors
Inivata Ltd – Key Employees
Inivata Ltd – Locations And Subsidiaries
Head Office
Recent Developments
Inivata Ltd, Recent Developments
Feb 27, 2020: Inivata’s Nitzan Rosenfeld to receive 2020 Cancer Researcher Award from the European Association for Cancer Research and Pezcoller Foundation
Oct 30, 2019: Inivata’s InVisionFirst-Lung test to be used for EORTC study
Oct 08, 2019: Novel approach based on InVision liquid biopsy platform predicts response to immune checkpoint inhibitors
Aug 29, 2019: Inivata to present new clinical data on the utility of liquid biopsy and InVisionFirst-Lung at World Conference on Lung Cancer 2019
Aug 12, 2019: Inivata appoints Jacqui Watson as Chief People Officer
Jul 18, 2019: Inivata announces launch of clinical trial to evaluate impact of InVisionFirst-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
Apr 26, 2019: Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst-Lung liquid biopsy test
Apr 16, 2019: Genomics England and industry partners complete first phase of liquid biopsy study
Mar 07, 2019: Inivata publishes positive results of clinical validation and utility study for InVision Liquid Biopsy Test
Mar 05, 2019: Inivata receives medicare final coverage decision for InVisionFirst-Lung Liquid Biopsy test in advanced Non-Small Cell Lung Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Inivata Ltd Pipeline Products and Ongoing Clinical Trials Overview
Inivata Ltd Pipeline Products by Equipment Type
Inivata Ltd Pipeline Products by Indication
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd, Key Facts
Inivata Ltd, Major Products and Services
Inivata Ltd Number of Pipeline Products by Development Stage
Inivata Ltd Pipeline Products Summary by Development Stage
Inivata Ltd Ongoing Clinical Trials by Trial Status
Inivata Ltd Ongoing Clinical Trials Summary
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Status
InVision ctDNA Assay - EGFR-Mutant NSCLC - Product Description
InVision ctDNA Assay - Metastatic Breast Cancer - Product Status
InVision ctDNA Assay - Metastatic Breast Cancer - Product Description
InVision ctDNA Assay - NSCLC - Product Status
InVision ctDNA Assay - NSCLC - Product Description
InVision ctDNA Assay - NSCLC - Feasibility Study of PD-L1 Expression Analysis on Circulating Tumor Cells by Immunocytochemistry and MDSCs Level Evolution Analysis in Non-small Cell Lung Cancer Treated with PD-L1 or PD1 Inhibitor
InVision ctDNA Assay - NSCLC - Liquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation: LIBERTI
InVision ctDNA Assay - Pancreatic Cancer - Product Status
InVision ctDNA Assay - Pancreatic Cancer - Product Description
InVision ctDNA Assay - Stage III/IV NSCLC - Product Status
InVision ctDNA Assay - Stage III/IV NSCLC - Product Description
Inivata Ltd, Key Employees
Glossary

★海外企業調査レポート[Inivata Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Plains All American Pipeline LP (PAA):企業の財務・戦略的SWOT分析
    Plains All American Pipeline LP (PAA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • CorEnergy Infrastructure Trust Inc (CORR):石油・ガス:M&Aディール及び事業提携情報
    Summary CorEnergy Infrastructure Trust Inc (CorEnergy) is an energy infrastructure real estate investment trust. The company owns assets in the midstream and downstream US energy sectors that perform functions, such as pipelines, storage terminals, and transmission and distribution assets. Its portf …
  • Immupharma Plc (IMM):企業の財務・戦略的SWOT分析
    Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic …
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • City Developments Ltd:企業の戦略・SWOT・財務情報
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • L.L. Bean, Inc.:企業の戦略・SWOT・財務情報
    L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report Summary L.L. Bean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CiMaas BV:製薬・医療:M&Aディール及び事業提携情報
    Summary CiMaas BV (CiMaas) develops cellular immunotherapies (vaccines) for the treatment of cancer. Its pipeline cellular therapeutic products include CIM101, a dendritic cell vaccine being developed using its proprietary maturation technology for the treatment of lung cancer; and CIM201, a haploid …
  • Sims Metal Management Limited:戦略・SWOT・企業財務分析
    Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Novotech (Australia) Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Novotech (Australia) Pty Ltd (Novotech) is a contract research organization that offers clinical development services. The organization’s services include clinical trials, data management, biostatistics analysis, audits, regulatory affairs, medical writing, site management and commercializat …
  • Hague and London Oil PLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Energy World Corp Ltd (EWC):電力:M&Aディール及び事業提携情報
    Summary Energy World Corp Ltd (Energy World) is an energy company that produces and sells power and develops liquiefied natural gas projects. The company's activities include design, construction, operation, and maintenance of independent power projects, liquefied natural gas plants, and gas process …
  • DaVita Inc.:戦略・SWOT・企業財務分析
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Northwestern Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Cognition Financial Corporation:企業の戦略・SWOT・財務情報
    Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognition Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • WellCare Health Plans Inc (WCG):企業の財務・戦略的SWOT分析
    WellCare Health Plans Inc (WCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tenaris SA:戦略・SWOT・企業財務分析
    Tenaris SA - Strategy, SWOT and Corporate Finance Report Summary Tenaris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AM Conservation Group Inc:電力:M&Aディール及び事業提携情報
    Summary AM Conservation Group Inc (AM Conservation) a subsidiary of Kohlberg & Company LLC is a clean technology company that manufactures, designs and distributes energy conservation products. The company provides products such as water conservation products, energy efficient products, energy effic …
  • Grasim Industries Limited:企業の戦略・SWOT・財務分析
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆